CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00485-07v1
15/6/974    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, N.
Right arrow Articles by Mukhopadhyay, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, N.
Right arrow Articles by Mukhopadhyay, S.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, June 2008, p. 974-980, Vol. 15, No. 6
1071-412X/08/$08.00+0     doi:10.1128/CVI.00485-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis {triangledown}

Nooruddin Khan,1 Kaiser Alam,1 Shiny Nair,1 Vijaya Lakshmi Valluri,2,{dagger} Kolluri J. R. Murthy,2 and Sangita Mukhopadhyay1*

Centre For DNA Fingerprinting and Diagnostics, ECIL Road, Hyderabad, India,1 Mahavir Hospital and Research Centre, Hyderabad, India2

Received 23 November 2007/ Returned for modification 4 February 2008/ Accepted 2 April 2008

Accurate diagnosis of tuberculosis (TB) infection is critical for the treatment, prevention, and control of TB. Conventional diagnostic tests based on purified protein derivative (PPD) do not achieve the required diagnostic sensitivity. Therefore, in this study, we have evaluated the immunogenic properties of Rv1168c, a member of the PPE family, in comparison with PPD, which is routinely used in the tuberculin test, and Hsp60 and ESAT-6, well-known immunodominant antigens of Mycobacterium tuberculosis. In a conventional enzyme immunoassay, the recombinant Rv1168c protein displayed stronger immunoreactivity against the sera obtained from patients with clinically active TB than did PPD, Hsp60, or ESAT-6 and could distinguish TB patients from Mycobacterium bovis BCG-vaccinated controls. Interestingly, Rv1168c antigen permits diagnosis of smear-negative pulmonary TB as well as extrapulmonary TB cases, which are often difficult to diagnose by conventional tests. The immunodominant nature of Rv1168c makes it a promising candidate to use in serodiagnosis of TB. In addition, our studies also show that Rv1168c is a potent T-cell antigen which elicits a strong gamma interferon response in sensitized peripheral blood mononuclear cells obtained from TB patients.

* Corresponding author. Mailing address: Centre for DNA Fingerprinting and Diagnostics, ECIL Road, Nacharam, Hyderabad 500076, Andhra Pradesh, India. Phone: 91-40-27151344, ext. 1305. Fax: 91-40-27155610. E-mail: sangita{at}cdfd.org.in

{triangledown} Published ahead of print on 9 April 2008.

{dagger} Present address: LEPRA, Blue Peter Research Centre, Hyderabad, India.

Clinical and Vaccine Immunology, June 2008, p. 974-980, Vol. 15, No. 6
1071-412X/08/$08.00+0     doi:10.1128/CVI.00485-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.